PharMerica has acquired PropacPayless, an independent senior living and long-term care pharmacy based in Vancouver, WA, from Moda Health. PropacPayless has more than 34,000 clients, primarily in the Northwest and West. With this new partnership, companies will build on PropacPayless’ customer relationships while using PharMerica’s scale, proximity and clinical programs to serve the senior living, […]
Note that we did not say it’s the single most important chart in all of US health care spending. Because it’s more than that. The magnitude of the difference in health treatment spending that The Most Important Chart encompasses illustrates that the hodgepodge of services and products we lump together as “health care” are widely divergent […]
Centene is leveraging its investment in RxAdvance to develop a more transparent PBM through Envolve Pharmacy Solutions
Specialty Pharmacy Market Overview – Market Shakeout Continuing into 2018 As the specialty drug spend grows, specialty pharmacies are playing an increasingly larger role in access and delivery of medications and services. The specialty pharmacy market, while dominated by a few large companies, has an increasing number of participants. AMI’s annual report, Specialty Pharmacy Market […]
Background on risk-sharing and insight into risk-sharing agreements from a payer’s and manufacturer’s perspective.
Provider Owned Commercial Health Plans. Provider-sponsored plans make up 15% or more of the health insurance market, and this percentage is growing, according to many of the projections by industry observers. Until recently, commercial health insurance products have, with only a few exceptions, been offered by health insurance companies. Now, health systems are increasingly assuming financial risk […]
Metro Areas Where Employers Influence Cancer Coverage Costs. Employers currently represent approximately 60% of the commercial insurance market dollars. The Employer commercial insurance market consists of more than 95,000 companies with self-insured plans, eighty percent of whom have less than 2,000 employees. Entering 2017, these employers face double-digit increases in the cost of prescription drugs […]
Outcome-Based Contracting Acceptance Grows in market with the concept of taking on financial risk on complex contracts as a result of market pressure combined with more familiarity. Outcome-based contracts between pharma companies and health insurers are becoming increasingly popular. In 2016, Novartis, Amgen, and Sanofi publicized risk-sharing, value-based, outcomes-based, or pay-for-performance deals, all of which vary […]